Background Locally advanced rectal cancer is usually treated with preoperative chemoradiation.
After chemoradiation and surgery, 15–27% of the patients have no residual viable …

Purpose Although combined-modality therapy (CMT) is the preferred treatment for T3 and/or
lymph node (LN)-positive rectal cancer, the German rectal cancer study published in 2004 …

In the last decades, the staggering progress in nanotechnology brought around a wide and
heterogeneous range of nanoparticle-based platforms for the diagnosis and treatment of …

Objective: To compare the efficacy and safety of antithrombotic prophylaxis given for 1 week
or 4 weeks in patients undergoing laparoscopic surgery for colorectal cancer. Background: …

BACKGROUND: Transanal local excision has been suggested as an attractive approach for
patients with rectal cancer who show a major clinical response after preoperative …

PURPOSE: The aim of this study was to evaluate factors associated with pathologic tumor
response following preoperative chemoradiation therapy, and the prognostic impact of …

Purpose: This study aimed to detect the M30 neoepitope on circulating tumor cells (CTC) as
a tool for quantifying apoptotic CTC throughout disease course and treatment. Experimental …

Purpose The circulating cell-free DNA (cfDNA) in plasma has been reported to be a marker
of cancer detection. The aim of this study was to investigate whether the cfDNA has a role as …

Background We performed this study to prospectively evaluate the postchemoradiotherapy
performance of transrectal ultrasonography (TRUS), pelvic computed tomography (CT) scan …

Recent literature suggests that the benefit of adjuvant chemotherapy (aCT) for rectal cancer
patients might depend on the response to neoadjuvant chemoradiation (CRT). Aim was to …